Morphic Holding, Inc. Gains 134.65%

Mon, Mar 01, 2021 at 05:30 PM
Morphic Holding, Inc. Gains 134.65%

Morphic Holding, Inc. (MORF:NASDAQ) shot up at $84.85, representing a gain of 134.7%. On Fri 26 Feb 21, MORF:NASDAQ touched a New 2-Week Intraday Low of $32.56. The stock appeared on our News Catalysts scanner on Mon 01 Mar 21 at 04:53 PM in the 'PUBLIC OFFERING' category. From Fri 12 Feb 21, the stock recorded 44.44% Up Days and 60.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Morphic Holding, Inc. (MORF:NASDAQ)

Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.